Dapagliflozin
7 NDCs across 2 manufacturers|2 Generic,5 Brand
Dapagliflozin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 8, 2014, and the first generic was approved Apr 6, 2026. FDA's Orange Book lists 32 AB-rated (therapeutically equivalent) products for this ingredient.
Dapagliflozin is available as 7 NDCs from 2 manufacturers (2 generic, 5 brand), with NADAC prices from $0.18 to $12.08 per EA — the most expensive product costs about 65× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
7
2G / 5B
Manufacturers
2
competing in market
Price Spread
$0.18 – $12.08
per EA
7d Activity
avg -0.0% WoW · of 7 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing DAPAGLIFLOZIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FARXIGA 10 MG TABLET | $12.0771 per EA | -0.04% |
FARXIGA 10 MG TABLET | $12.0771 per EA | -0.04% |
FARXIGA 10 MG TABLET | $12.0771 per EA | -0.04% |
FARXIGA 5 MG TABLET | $12.0755 per EA | -0.04% |
FARXIGA 5 MG TABLET | $12.0755 per EA | -0.04% |
DAPAGLIFLOZIN 10 MG TABLET | $0.2049 per EA | — |
DAPAGLIFLOZIN 5 MG TABLET | $0.1845 per EA | — |
Frequently Asked Questions
What is Dapagliflozin used to treat?
Dapagliflozin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Dapagliflozin become available as a generic?
FDA approved the first generic Dapagliflozin (ANDA) on Apr 6, 2026. The Orange Book currently lists 32 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Dapagliflozin products are on the market?
The Dapagliflozin drug market contains 7 NDCs from 2 manufacturers — 2 generic and 5 brand products.
What is the price range for Dapagliflozin?
NADAC reference prices for Dapagliflozin range from $0.1845 to $12.0771 per EA — the most expensive product costs about 65× the cheapest.
Is generic Dapagliflozin cheaper than brand?
The average generic NADAC for Dapagliflozin is $0.1947 per EA, versus $12.0765 for brand-labeled products — brand versions average about 62× the generic price.
Which manufacturers make Dapagliflozin?
2 manufacturers list Dapagliflozin in NADAC. Ranked by number of NDCs, the largest are AstraZeneca Pharmaceuticals LP (5), Prasco Laboratories (2).
How has the price of Dapagliflozin changed recently?
Over the past 7 days, 0 Dapagliflozin NDCs rose and 5 fell, with a market-wide average change of -0.0%.